Florida bans Medicaid from covering ‘gender transition’ drugs, surgeries

The Florida Agency for Health Care Administration on Thursday added the new language to the state’s $36.2 billion Medicaid program, declaring that the program will not cover treatments such as puberty blockers, hormone therapies or surgical procedures as a treatment for gender dysphoria. The updated rule will take effect on August 21, reported Politico.

A June report from the state's Medicaid office stated that "as a condition of coverage, sex reassignment treatment must be 'consistent with generally accepted professional medical standards (GAPMS) and not experimental or investigational,'" as determined by the deputy secretary for Medicaid.

A coalition of LGBTQ+ and health rights groups, including Lambda Legal, Southern Legal Counsel, Florida Health Justice Project, and National Health Law Program, claim the lack of state-funded transition procedures are "discriminatory."

"Ignoring thousands of public comments and expert testimony, Florida's AHCA has finalized a rule that will deny Medicaid coverage for all medically necessary gender-affirming care for both youth and adults," the coalition statement said. "This discriminatory and medically unsound rule will take effect on August 21, 2022, putting transgender people in jeopardy of losing access to critical gender-affirming health care services."

The move by Florida Medicaid has sparked some controversy and will most likely lead to lawsuits, with self-proclaimed "trans scientist" Zinnia Jones taking to Twitter to call for transgender plaintiffs to join her in taking legal action.

Gov. DeSantis's press secretary, Christina Pushaw, denounced the use of the term "gender-affirming care," in reference to the new rule, citing a case of a de-transitioned woman who underwent harmful procedures under the guise of "affirmation."